Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

Maintenance treatment with vedolizumab (Entyvio) appeared to be safe and effective in children with inflammatory bowel disease (IBD), with greater effectiveness in those with ulcerative colitis ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

known as Entyvio SC, Spherix captured the initial impact of the launch on the EU5 Crohn’s disease (CD) and ulcerative colitis (UC) markets through their RealTime DynamixTM services. The latest ...

AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first ... and Takeda Pharma’s α4β7 inhibitor Entyvio (vedolizumab), both of which are ...

of golimumab were able to see improvements in ulcerative colitis by week 30 of treatment. This was compared to 15.6% of ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Treatment with Entyvio is the same for ulcerative colitis, Crohn’s disease and pouchitis. The recommended dose of Entyvio is 300 mg per infusion. Following the initial dose, you will get ...